Abstract
Purpose To evaluate the associations of retinal vascular complexity features, including fractal dimension (FD) and blood vessel tortuosity (BVT), with the severity of diabetic retinopathy (DR) by using noninvasive optical coherence tomographic angiography (OCTA).
Methods This prospective cross-sectional study recruited ocular-treatment-naïve patients with type 2 diabetes mellitus (DM) registered in the community of Guangzhou, China. OCTA was used to obtain the measurements of FD and BVT in the superficial capillary plexus (SCP) and the deep capillary plexus (DCP). Univariate and multivariate linear regression was used to analyse the correlation of FD and BVT in different layers with DR severity.
Results A total of 1282 patients with DM (1282 eyes), with a mean age of 64.2±7.8 years, were included. FD in the DCP decreased and BVT in the DCP increased in DR patients compared to non-DR patients, even after adjusting for confounding factors (P< 0.05). Trend analysis showed a significant decrease in the FD values as the DR progressed, while the BVT progressively increased with worsening DR severity (P< 0.01). The FD in DCP had a statistically significant positive correlation with FD in SCP and a negative correlation with BVT in SCP and BVT in DCP in all of the participants, including the non-DR group, moderate DR group and severe DR group (P< 0.01).
Conclusion FD and BVT determined using OCTA might be useful parameters for objectively distinguishing DR from non-DR and indicating DR progression.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ISRCTN registry no: 15853192
Funding Statement
This research was supported by the National Natural Science Foundation of China (82000901), the Fundamental Research Funds of the State Key Laboratory of Ophthalmology (303060202400362).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Medical Ethics Committee of the Zhongshan Ophthalmic Centre approved the study (2017KYPJ094)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding information: This research was supported by the National Natural Science Foundation of China (82000901, 82102993), the Fundamental Research Funds of the State Key Laboratory of Ophthalmology (303060202400362), Guangdong Basic and Applied Basic Research Foundation (2019A1515110618) and the Research and Development Foundation of Dongguan People’s Hospital (201900181, K202008).
Disclosure: J. Liu, None; S. Chen, none; Z. Xu, None; W. Wang, None; D. Wang, None; Y. Su, None; S. Zhao, None; M. Li, None; F. Chen, None; C. Zuo, None; M. Chen, None.
Data Availability
Data can be available when approprieate request.